- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 55.37M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $216.74M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $247.53M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $25.88M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $26.79M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $499K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $898K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $174.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $143.97M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $28.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $44.7M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $259.3M |
| Total Assets restated | Q1 2025 · Mar 31, 2024 | $259.3M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 41.89M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.58M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$232.14M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$216.98M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.58 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.58 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $8.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$24.23M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$9.46M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$612K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $73.25M |